Onxeo changes its name and becomes Valerio Therapeutics following approval by the Annual General Meeting of June 6, 2023 - Marketscreener.com
| C4X Stock | EUR 0.07 0.0001 0.14% |
Roughly 54% of Onxeo SA's investor base is interested to short. The analysis of current outlook of investing in Onxeo SA suggests that many traders are impartial regarding Onxeo SA's prospects. The current market sentiment, together with Onxeo SA's historical and current headlines, can help investors time the market. In addition, many technical investors use Onxeo SA stock news signals to limit their universe of possible portfolio assets.
Onxeo SA stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Onxeo daily returns and investor perception about the current price of Onxeo SA as well as its diversification or hedging effects on your existing portfolios.
Onxeo |
Onxeo changes its name and becomes Valerio Therapeutics following approval by the Annual General Meeting of June 6, 2023 Marketscreener.com
Read at news.google.com
 |
Onxeo SA Fundamental Analysis
We analyze Onxeo SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Onxeo SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Onxeo SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Onxeo SA is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Onxeo SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Onxeo SA stock to make a market-neutral strategy. Peer analysis of Onxeo SA could also be used in its relative valuation, which is a method of valuing Onxeo SA by comparing valuation metrics with similar companies.
Peers
Onxeo SA Related Equities
| RS6 | Reliance Steel | 1.01 | ||||
| 8SP | Superior Plus | 0.92 | ||||
| 3RKU | RYOHIN UNSPADR1 | 1.92 | ||||
| TM9 | NorAm Drilling | 2.03 | ||||
| NOH1 | Norsk Hydro | 2.72 | ||||
| 22UA | BioNTech | 4.43 | ||||
| 2DG | SIVERS SEMICONDUCTORS | 5.88 | ||||
| 0QF | Moderna | 6.84 |
Complementary Tools for Onxeo Stock analysis
When running Onxeo SA's price analysis, check to measure Onxeo SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Onxeo SA is operating at the current time. Most of Onxeo SA's value examination focuses on studying past and present price action to predict the probability of Onxeo SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Onxeo SA's price. Additionally, you may evaluate how the addition of Onxeo SA to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |